Patents by Inventor Branden Moriarity

Branden Moriarity has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190060364
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: November 6, 2018
    Publication date: February 28, 2019
    Inventors: Branden MORIARITY, Beau WEBBER, Modassir CHOUDHRY, Steven A. Rosenberg, Douglas C. PALMER, Nicholas P. RESTIFO
  • Publication number: 20190054122
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: November 5, 2018
    Publication date: February 21, 2019
    Inventors: Branden Moriarity, Beau Webber, Modassir Choudhry, Steven A. Rosenberg, Douglas C. Palmer, Nicholas P. Restifo
  • Publication number: 20190008899
    Abstract: Genetically modified compositions, such as non-viral vectors and tumor infiltrating lymphocytes, for the treatment of gastrointestinal cancer are disclosed. Disclosed are methods of utilizing a CRISPR system to generate genetically modified compositions. Also disclosed are the methods of making and using the genetically modified compositions for the treatment of gastrointestinal cancer.
    Type: Application
    Filed: April 6, 2018
    Publication date: January 10, 2019
    Inventors: Branden MORIARITY, Beau WEBBER, Modassir CHOUDHRY, Steven A. ROSENBERG, Douglas C. PALMER, Nicholas P. RESTIFO
  • Patent number: 10166255
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: January 1, 2019
    Assignees: REGENTS OF THE UNIVERSITY OF MINNESOTA, INTIMA BIOSCIENCE, INC., THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES
    Inventors: Branden Moriarity, Beau Webber, R. Scott McIvor, Modassir Choudhry, Steven A. Rosenberg, Douglas C. Palmer, Nicholas P. Restifo
  • Publication number: 20180327726
    Abstract: This disclosure provides various TcBuster transposases and transposons, systems, and methods of use.
    Type: Application
    Filed: June 11, 2018
    Publication date: November 15, 2018
    Inventors: David LARGAESPADA, Branden MORIARITY, Beau WEBBER, Neil OTTO, Sandeep KUMAR, Leah HOGDAL
  • Publication number: 20180245055
    Abstract: This disclosure provides various TcBuster transposases and transposons, systems, and methods of use.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 30, 2018
    Inventors: David LARGAESPADA, Branden MORIARITY, Beau WEBBER, Neil OTTO, Sandeep KUMAR, Leah HOGDAL
  • Publication number: 20180216087
    Abstract: This disclosure provides various TcBuster transposases and transposons, systems, and methods of use.
    Type: Application
    Filed: December 15, 2017
    Publication date: August 2, 2018
    Inventors: David Largaespada, Branden Moriarity, Beau Webber, Neil OTTO, Sandeep KUMAR, Leah HOGDAL
  • Publication number: 20170130200
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: July 29, 2016
    Publication date: May 11, 2017
    Inventors: Branden MORIARITY, Beau WEBBER, R. Scott MCIVOR, Modassir CHOUDHRY
  • Publication number: 20170119820
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: July 29, 2016
    Publication date: May 4, 2017
    Inventors: Branden MORIARITY, Beau WEBBER, R. Scott MCIVOR, David LARGAESPADA, Modassir CHOUDHRY
  • Publication number: 20170067021
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: September 2, 2016
    Publication date: March 9, 2017
    Inventors: Branden Moriarity, Beau Webber, Modassir Choudhry, R. Scott McIvor, David Largaespada
  • Publication number: 20170065636
    Abstract: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
    Type: Application
    Filed: August 29, 2016
    Publication date: March 9, 2017
    Inventors: Branden Moriarity, Beau Webber, Modassir Choudhry